Shares of Bausch Health Companies Inc (BHC) are trading -50% lower at a price of $4.317 at the time of this writing.
- Delaware federal judge ruled on a patent-related issue related to the company's Xifaxan drug
Bausch Health Companies Inc has been trading between a 52-week high of $30.01 and a 52-week low of $4. The stock has a market cap of $1.56 Billion.
Bausch Health Companies Inc. (NYSE/TSX: BHC) is a global company whose mission is to improve people's lives with our health care products. We develop, manufacture and market a range of pharmaceutical, medical device and over-the-counter products, primarily in the therapeutic areas of eye health, gastroenterology and dermatology.
Headlines
Toronto stocks slip as mixed earnings, Bausch Health weigh
Financial Post 07-28-22
Toronto stocks slip as mixed earnings, Bausch Health weigh
Reuters 07-28-22
Bausch Health plummets 50% following judge''s Xifaxan patent order (NYSE:BHC)
Seeking Alpha 07-28-22
Better Therapeutics, GeoVax top healthcare gainers; Community Health, Bausch lead losers'' pack
Seeking Alpha 07-28-22
Bausch Health Companies Inc. Will Release Second-Quarter 2022 Financial Results on Aug. 9
PR Newswire 07-27-22
As you can imagine, the internet had a few things to say about the price move. Here's a few choice comments from the Reddit Traderverse™:Tbones014 - 4 upvotes -
sourceCramer claims more victims after recommending BHC
Sure-Ad7730 - 2 upvotes -
sourceHalt on BHC I was just about to jump in.
nationalizm - 1 upvotes -
sourceImagine buying BHC puts yesterday lmao do they actually pay those options out for 15k gains if there’s no volume on them?
le_pedal - 1 upvotes -
sourceBHC